Starpharma Holdings Limited (ASX:SPL)
Australia · Delayed Price · Currency is AUD 0.7000
+0.0250 (3.70%)
May 29, 2026, 4:10 PM AEST
Starpharma Holdings Market Cap
Starpharma Holdings has a market cap or net worth of 294.8 million as of May 29, 2026. Its market cap has increased by 701.02% in one year.
Market Cap
294.80M
Enterprise Value
277.35M
Revenue
14.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.70
Market Cap Chart
Since September 28, 2000, Starpharma Holdings's market cap has increased from 50.00M to 294.80M, an increase of 489.61%. That is a compound annual growth rate of 7.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 294.80M | 95.80% |
| Dec 31, 2025 | 150.56M | 227.36% |
| Dec 31, 2024 | 45.99M | -34.30% |
| Dec 29, 2023 | 70.01M | -68.87% |
| Dec 30, 2022 | 224.87M | -58.74% |
| Dec 31, 2021 | 544.95M | -14.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Opthea | 738.77M |
| Racura Oncology | 473.36M |
| Clinuvel Pharmaceuticals | 460.41M |
| Tetratherix | 371.10M |
| Orthocell | 208.27M |
| Recce Pharmaceuticals | 159.05M |
| Actinogen Medical | 143.65M |
| Nyrada | 122.47M |